Active, not recruitingNCT05868148

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

Studying Avascular necrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stryker Trauma and Extremities
Principal Investigator
Rebecca Gibson
Stryker Trauma and Extremities
Intervention
Shoulder iD™ Primary Reversed Glenoid(device)
Enrollment
200 enrolled
Eligibility
18 years · All sexes
Timeline
20232035

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05868148 on ClinicalTrials.gov

Other trials for Avascular necrosis

Additional recruiting or active studies for the same condition.

See all trials for Avascular necrosis

← Back to all trials